Measuring the diffusion of palliative care in long-term care facilities – a death census by Paroz, Sophie & Santos-Eggimann, Brigitte
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
BMC Palliative Care
Open Access Research article
Measuring the diffusion of palliative care in long-term care facilities 
– a death census
Sophie Paroz* and Brigitte Santos-Eggimann
Address: Institute of Social and Preventive Medicine (IUMSP), Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, 
Switzerland
Email: Sophie Paroz* - sophie.paroz@chuv.ch; Brigitte Santos-Eggimann - brigitte.santos-eggimann@chuv.ch
* Corresponding author    
Abstract
Background:  The dissemination of palliative care for patients presenting complex chronic
diseases at various stages has become an important matter of public health. A death census in Swiss
long-term care facilities (LTC) was set up with the aim of monitoring the frequency of selected
indicators of palliative care.
Methods:  The survey covered 150 LTC facilities (105 nursing homes and 45 home health
services), each of which was asked to complete a questionnaire for every non-accidental death over
a period of six months. The frequency of 4 selected indicators of palliative care (resort to a
specialized palliative care service, the administration of opiates, use of any pain measurement scale
or other symptom measurement scale) was monitored in respect of the stages of care and analysed
based on gender, age, medical condition and place of residence.
Results:  Overall, 1200 deaths were reported, 29.1% of which were related to cancer. The
frequencies of each indicator varied according to the type of LTC, mostly regarding the
administration of opiate. It appeared that the access to palliative care remained associated with
cancer, terminal care and partly with age, whereas gender and the presence of mental disorders
had no effect on the indicators. In addition, the use of drugs was much more frequent than the
other indicators.
Conclusion: The profile of patients with access to palliative care must become more diversified.
Among other recommendations, equal access to opiates in nursing homes and in home health
services, palliative care at an earlier stage and the systematic use of symptom management scales
when resorting to opiates have to become of prime concern.
Background
With an aging population, palliative care has been
increasingly discussed in recent years and has developed
into a separate medical specialization that differs from
and is complementary to curative care. Historically, palli-
ative care was originally intended for patients suffering
from a cancer or a terminal illness. Both the definition
and the objectives of such care have recently been rede-
fined, to include patients presenting with any complex
chronic disease and to offer such care early in the course
of the illness [1]. Following these redefinitions, numerous
development programs have been set up and training
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courses as well as specialized structures are now available
in many countries and areas [2-7].
In Switzerland, where palliative care are included in the
basket of services covered by the Swiss obligatory health
insurance, the State of Vaud financed a five-year (2002–
2007) palliative care development program the aim of
which was to offer every patient equal access to such care,
irrespective of age, pathology and place of residence. The
program intended to develop palliative care for stabilised
chronic patients as well as for complex intensive situa-
tions, at home, in LTC institutions as well as in hospitals
and to train primary health care providers as well as spe-
cialists. The initial steps of the program were the improve-
ment of professional training in the field of palliative care
(including for LTC professionals), the establishment of a
mobile palliative care teams for each region of the state,
the creation of a sub-acute hospital palliative care service
and the creation of an academic chair of palliative care.
These first measures intended to disseminate palliative
care in all care settings and places of residence.
When reviewing the results of other studies [8-11], the dis-
semination of palliative care across various demographic
strata, various medical conditions and various stages of
disease can be questioned. An important question at the
present time, after years of reorganization, is to ascertain
whether a wider variety of patients really does have access
to palliative care. This question is a relevant public health
issue, as is the need to improve the knowledge for deliver-
ing palliative care in all settings for a large range of condi-
tions [12-15].
With this objective in mind, we set up a death census in
long-term care facilities (LTC), with the aim of monitor-
ing the frequency of various indicators of palliative care,
in respect of age and gender, type of disease, place of resi-
dence, complexity of the situation (i.e. when mental dis-
orders, usually dementia, are part of the problem) and




The survey was conducted by the Institute of Social and
Preventive Medicine at the University of Lausanne as part
of the evaluation of the state initiative for promoting pal-
liative care [16]. It analysed the circumstances of non-acci-
dental deaths over a period of six months in beneficiaries
of LTC residing in this Swiss region of 660'000 inhabit-
ants. Two kinds of LTC structures were surveyed: a) home
health services (HHS) that provide help and care, in col-
laboration with private primary care practitioners, to
patients living at home and b) nursing homes or hospital
services for chronic patients (NH) that take care of institu-
tionalized patients. This target population was selected
because it was highly susceptible to present (and die
from) progressive chronic diseases and, therefore, to need
palliative care early or late during the last year of life. The
combination of these two types of LTC institutions also
covered a wide range of patients regarding age, diagnosis
and place of residence (including institutionalized and
community-dwelling patients).
Every public or private NH and HHS (203 structures in
total) was contacted in Spring 2006 and invited to take
part in the research. Overall, the survey covered 150 LTC
institutions (73.9%), including 105 NH (out of 158,
66.5%) and all HHS (45, 100%). Participating NH
accounted for 4451 beds (72.1% of all LTC beds). Non-
participating NH were mainly psychiatric institutions
characterized by younger patients and a lower level of
mortality.
Data collection
Participating LTC institutions completed a short, anony-
mous questionnaire for each non-accidental death among
their patients from June 15, 2006 to December 15, 2006,
including those deaths that occurred in another setting
(e.g. in an acute care hospital). If no death occurred in a
given month, they returned a form announcing the
absence of any event. One person per institution, usually
a nurse, was designated to collect the questionnaires and
forms, return them to the research centre on the 15th of the
month and respond to any questions about the records. In
order to check the data, the first author systematically con-
tacted the LTC when confronted with incomplete or con-
tradictory data.
Questionnaire and indicators of palliative care
The questionnaire was drawn up in the research centre,
discussed with a working-group made up of NH and HHS
health professionals and pre-tested on 74 fatalities. The
pre-test intended to check the understanding of the items
by LTC health professionals, which appeared to be good.
It covered general characteristics such as age category, gen-
der, transfers between institutions, place of death, pres-
ence of a diagnosis of cancer or recognized mental
disorders that were part of the patient's situation. Four
indicators of palliative care were included in the reporting
form: a) recourse to a specialized palliative care service
(SPCS) such as a mobile team, a call service or a hospital-
based unit, b) the administration of opiates, c) the use of
any pain measurement scale and d) the use of any other
symptoms measurement scale. The state program had no
quantifiable expectations regarding these specific indica-
tors and their selection was guided by pragmatic reasons;
they had to be clearly associated to the practice of pallia-
tive care, likely to be known by LTC professionals in
charge of the deceased patient and registered in the medi-BMC Palliative Care 2009, 8:1 http://www.biomedcentral.com/1472-684X/8/1
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cal file of deceased patients. Palliative care indicators were
measured only for the care provided within or in collabo-
ration with the LTC institutions. Moreover, each indicator
was recorded both for the last ten days of life (late care)
and for the last year of life up to the last ten days (early
care). The choice of limiting late care to the last ten days
was also guided by pragmatism because we were not in a
position to decide what late  and  early  palliative care
should be in each case.
In order to avoid double counting, patients transferred
between LTC structures shortly before death were counted
only in the last institution in charge.
Statistical analysis
Descriptive statistics first depicted the general characteris-
tics of the entire population of deaths occurring in LTC.
Analyses then successively compared the profile of
deceased patients in NH and HHS, with and without can-
cer, and presenting with or without mental disorders as a
component of their situation. Analyses of palliative care
indicators followed the same sequence. Finally, subgroup
analyses studied whether recourse to a SPCS and adminis-
tration of opiates, respectively, were each associated with
higher levels of other palliative care indicators. In all
cases, the subpopulations were compared by means of
chi-squared and Fisher's exact tests using the STATA 9 soft-
ware.
Results
Of the 1252 fatalities reported, 52 were excluded: 49 ques-
tionnaires (42 received from HHS and 5 from NH) were
considered as potential duplicates related to transfers, 2
HHS cases were revealed to be accidental deaths, and in
one NH case the death concerned the tenant of an apart-
ment not covered by the survey of LTC patients.
Consequently, a total of 1200 valid death cases reported
by the LTC facilities were analysed. The 105 participating
NH accounted for more than half of the institutions
recorded in the survey (n = 632, 52.7%). On the basis of
the latest official NH statistics in Vaud we would have
expected 626 cases in the participating institutions. The
number of deaths reported by HHS (n = 568, 47.3%) was
however lower than expected on the basis of the statistics
of the HHS association in Vaud (726 cases recorded dur-
ing the study period).
General characteristics of deaths in LTC facilities
Half of the patients who died were over 85 years of age
and more than 4 out of 10 were in the age category of 64–
85 years. Women formed the majority, and about a third
of the population was diagnosed with cancer or presented
mental disorders (dementia and severe depression)
(Additional file 1). The NH subpopulation of deaths had
significantly higher proportions of women, very old
patients and patients with mental disorders recorded at
death, but a lower proportion of cancer diagnoses. Among
the HHS deaths, men were more numerous than women.
Additional file 1 also shows major demographic differ-
ences between deceased LTC patients with and without a
diagnosis of cancer. The male to female ratios were 1.3
when a cancer was recorded and 0.6 when no cancer was
declared. Three quarters of cancer-related deaths occurred
before the age of 85 years (while 6 out of 10 persons died
at 85 years or older when no cancer was reported).
Reports of mental disorders in the last year of life were not
related to the age or gender of the deceased LTC patients.
However, they were significantly less frequent in cancer
cases. Cancer was diagnosed in 19.8% of LTC patients
dying with mental disorders and in 33.8% of deceased
patients who did not have a mental disorder. The fact that
missing values were more important regarding the pres-
ence of mental disorders than they were for other varia-
bles may be related to the difficulty of making such a
diagnosis with old patients.
Frequency of the palliative care indicators
Indicators of palliative care were more frequently positive
during the last 10 days than earlier in the last year of life
in all cases, with the unique exception of access to an SPCS
for the NH subpopulation. The difference between late
and early palliative care was more pronounced for the NH
subpopulation, particularly regarding the access to opi-
ates.
Consultation of an SPCS was more often reported for
HHS patients than for NH patients in the ten days before
death (p < 0.001) or earlier in the last year of life (p <
0.001). In both settings, however, the frequency of
recourse to SPCS was low. The administration of opiates
in the very last days of life was noticeably more often
recorded for the NH patients than for the HHS patients (p
< 0.001), while it was the same for both types of LTC ear-
lier in the run-up to death. The highest frequency of
recourse to pain measurement scales was observed for late
care in NH (one case out of 5 versus one out of 8 in HHS,
p < 0.05). Nevertheless, the use of pain or other symptom
measurement scales was not standard in either setting,
whether at a late or early stage in the course of the illness.
Overall, and in the two subgroups of patients with or
without cancer, gender had no effect on indicators of pal-
liative care. Age, however, was partly associated with the
indicators. For the HHS subpopulation with a diagnosis
of cancer, the proportion of positive indicators per age cat-
egory varied significantly. It decreased in line with age,
with a higher proportion of positive indicators in theBMC Palliative Care 2009, 8:1 http://www.biomedcentral.com/1472-684X/8/1
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youngest group (16–64 years old) and a lower proportion
in the oldest group (> 85 years old). By contrast, there was
no relationship between the indicators of palliative care
and age in the HHS subpopulation without a cancer diag-
nosis, where proportions were generally low for all indica-
tors. In NH, no significant effect of age was observed,
except for early consultation of an SPCS, which was more
frequent in the group of 65–85 year-old patients than in
the 85+ age group, both for patients with and without a
diagnosis of cancer. The small number of patients aged
less than 65 precludes any interpretation of the indicators
for the youngest subjects in NH.
All indicators of early and late palliative care were signifi-
cantly more likely to be positive in the presence of cancer,
for deceased patients in NH and to a greater extend for
deceased patients in HHS (Additional file 2). By contrast,
no significant difference was observed regarding the fre-
quency of positive indicators in the presence or absence of
reported mental disorders complicating the situation,
overall and in both settings.
Interaction between consultation of a specialized 
palliative care structure and other indicators
The hypothesis of specific care for people who had access
to an SPCS was verified in both settings. Recourse to opi-
ates, pain measurement scales or any other symptom
measurement scales was much more frequently recorded
in this subpopulation, whether early or late in the course
of the illness. Apart from one case, all the differences were
statistically significant (Additional file 3).
Interaction between administration of opiates and other 
indicators
The extent to which the administration of opiates consti-
tutes part of a palliative care approach can be investigated
through the association with other indicators (Additional
file 4). The frequency of access to SPCS and the use of pain
or other symptom measurement scales was significantly
higher in patients who received opiates both early and late
in their disease.
However, in a large majority of cases, the administration
of opiates did not involve the use of symptom measure-
ment scales or the consultation of a specialized structure
providing advice for palliative care. Although the admin-
istration of opiates was less frequently reported for HHS
patients, it was more often registered in association with
other indicators of palliative care than in NH patients.
Discussion
Because of the importance of chronic diseases associated
with multiple symptoms – cancer being only one example
– the availability and dissemination of palliative care
should be everyone's concern. The survey intended to
check if there was evidence of a palliative care awareness
among healthcare professionals and if this type of care is
easily accessible to dying and sick people.
This essentially descriptive study focused on the frequency
of selected indicators of palliative care regarding different
groups of people. Most of the results were close to what
could have been expected given the historical culture of
palliative care and its usual association with terminal care
and cancer. However, a number of interesting observa-
tions emerged, partly regarding the way in which the dif-
fusion is measured and partly regarding the actual
diffusion of palliative care.
Data collection
The difference between the number of deaths reported to
us by HHS and the number reported in their official statis-
tics may be explained by accidental deaths, which were
intentionally excluded from our survey but included in
the statistics of the HHS association. The fact that we
excluded from the HHS census the deaths of patients ulti-
mately transferred to an NH and attributed them to the
NH is another likely explanation.
The choice of indicators
Measuring the access and dissemination of palliative care,
which involves a variety of medical, social and psycholog-
ical factors, is a complex undertaking and finding relevant
indicators for measuring this phenomenon was even
more difficult, since it involved a population of patients
presenting various complex situations: the palliative care
needs of patients with cancer are better defined and
known by health professionals, while there is a lack of
expertise as regards non-cancer patient care [17,18]. In
addition, we were limited by the information systemati-
cally registered in the patient files of the LTC, which pre-
vented us from chosing psychosocial indicators, for
example.
Two elements have to be kept in mind concerning the four
indicators of palliative care that were chosen. They do not
claim to be exhaustive regarding the practice of palliative
care and only measure part of the work done in the
selected health services and area. They were designed to
test the dissemination of palliative care and must there-
fore not be understood as indicators of quality of care:
resort to an SPCS, opiates or symptom measurement
scales is not justified in every clinical situation, and the
survey did not purport to evaluate care provided in indi-
vidual cases. The objective of the study was to measure the
extend of use of palliative care through these indicators.
We are satisfied that this objective was reached.BMC Palliative Care 2009, 8:1 http://www.biomedcentral.com/1472-684X/8/1
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A persistent tradition of care
Some of the results illustrated traditional views of pallia-
tive care, i.e. its association with terminal care, cancer and
pain drugs [19]. Indeed, the access to palliative care
appeared to be better late in the course of the illness and
when cancer was also involved, while palliative care now-
adays is precisely intended for patients presenting any
complex chronic disease at any stage in its development.
In addition, the recourse to opiates was much more fre-
quent than all other indicators, yet palliative care must
not be reduced to the administration of analgesic drugs.
Encouraging signs of diffusion
Wherever palliative care appeared to be still associated
with cancer and partly with age, gender and the presence
of mental disorders had, by contrast, no effect on the
access to palliative care. We expected worse access to pal-
liative care for people presenting with mental disorders
since they have specific needs [20], are more likely to
experience difficulty in expressing their symptoms, may
be more at risk regarding discrimination but also since it
is more difficult for professionals to assess pain and symp-
tom in these cases. This would result in a less frequent use
of symptom measurement scales and a more frequent use
of opiates; however, the above-mentioned indicators were
not found to be dependant on the complexity of a situa-
tion characterized by mental disorders, a finding consist-
ent with other recent Swiss results [21].
The finding of better access to palliative care when a spe-
cialized structure has been consulted accords with the lit-
erature review of Sykes and Thorns [22] and highlights the
importance of training specialists and continuing to
develop specific structures in order to disseminate pallia-
tive care.
Worrying discrepancies
As mentioned previously, the characteristics of dying LTC
patients who still lived at home appeared to differ from
those of dying patients residing in institutions. This may
explain most of the variations in the frequency of positive
indicators observed for the two types of LTC. Some results
may also be related to the medical culture of the LTC
[23,24], especially the much higher proportion of SPCS
consultations for the HHS subpopulation and the very
much higher use of opiates in the last 10 days of life in the
NH. However, this discrepancy regarding access to pallia-
tive care related to the place of residence is inconsistent
with the affirmation of equal access to palliative care irre-
spective of place of residence or place of care.
The gap observed between late and early care is another
matter of concern. Patients appeared to receive palliative
care more often in their last ten days of life than earlier in
the development of the disease. Other authors found that
the use of opiates increased during the last week [25]. This
observation runs counter to the wish of not limiting palli-
ative care to terminal care.
Finally, the large proportion of patients who received opi-
ates without any indication of the use of symptom meas-
urement scales calls into question the sensitivity of this
indicator when measuring the practice of palliative care.
Without a simultaneous recourse to the systematic moni-
toring of the symptoms, which must be documented in
the patient file in order to ensure an adequate communi-
cation between the multiple professionals involved in the
care needed by many dying patients, we may wonder
whether the administration of opiates can be considered
as palliative care. In fact, the interpretation of the four
indicators, when taken separately, is limited and, in the
current state of knowledge, we lack a gold standard (such
as the appropriate proportion of non-cancer deaths that
would justify the prescription of an opiate) that would
help to interpret their level. More than the absolute value
of any individual indicator, the interaction of these indi-
cators as well as their variations across demographic strata
are more useful in providing information on the dissemi-
nation of palliative care.
Conclusion
The observation of various discrepancies leads to several
recommendations. The profile of the patients with access
to palliative care must be adapted to the recent redefini-
tion of palliative care and become more diversified. Palli-
ative care earlier than in the last ten days of life has to be
a prime concern. The recourse to opiates has to be accom-
panied by a more systematic monitoring of pain. More
generally, the monitoring of symptoms must become
widespread, whether with or without the use of drugs
[26], and there should be less discrepancy in respect of
access to palliative care between community-dwelling and
institutionalized patients. Finally, it would be very useful
to know the frequency of palliative indicators for patients
presenting various complex situations, not only for
patients with cancer, in other areas or countries.
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Additional file 1. Characteristics of the reported deaths, overall, per type 
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Additional file 2. Frequencies of the indicators of palliative care, overall, 
per type of LTC and according to the presence of a diagnosis of cancer.




Additional file 3. Relation between the recourse to a specialized palliative 
care structure (SPCS) and the other indicators palliative care, per type of 
LTC.
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